Two adults of the same height and weight can have very different health profiles. The difference is often not the number on the scale, but where the fat sits.
The form of body fat that matters most for long-term health doesn't show on a bathroom scale. It sits behind the abdominal wall, surrounding the liver, pancreas and intestines. It is metabolically active in ways that the fat under the skin is not — and the published research consistently shows it is the form most closely associated with cardiometabolic risk.
It is called visceral fat. And it is what most weight charts miss.
What visceral fat is
Body fat is not a single tissue. It comes in two broad forms.
The first, subcutaneous fat, sits between the muscle and the skin. It is the fat you can pinch. Functionally, it stores energy, insulates the body, and tends to be relatively metabolically quiet.
The second, visceral fat, sits deeper. It surrounds the abdominal organs and produces a steady stream of inflammatory signals, hormones, and free fatty acids that influence the rest of the body's metabolism¹.
Two people can carry the same total weight — and one can have substantially more visceral fat than the other. The implications, clinically, are rather different.
Why scales and BMI miss it
A bathroom scale measures total weight. BMI compares weight to height. Neither distinguishes between fat and muscle, and neither distinguishes between fat that sits under the skin and fat that sits around the organs.
Two adults can share an identical BMI and have visceral fat volumes that differ by more than a factor of two. This is one of the well-documented limitations of using BMI alone in clinical assessment, and it is the reason most up-to-date guidelines (including NICE NG246, updated in 2025) now recommend that BMI be considered alongside a waist measurement².
Many patients arrive at consultation having been told for years that their weight is 'fine' by BMI standards, only to discover — when they are properly measured — that the visceral fat they carry is the part the chart never showed.
What the published research keeps showing
The clinical literature on visceral fat is unusually consistent. Across cardiometabolic medicine, the same pattern emerges from independent research groups, in different populations, using different measurement methods.
Cardiometabolic disease risk
Visceral adiposity is associated with elevated risk of type 2 diabetes, hypertension, dyslipidaemia, non-alcoholic fatty liver disease and atherosclerotic cardiovascular disease — and the relationship is independent of total body weight³.
Cognitive decline
Research published in the Annals of Neurology has shown an association between elevated visceral adiposity in midlife and accelerated cognitive decline later in life — even in adults whose total weight was within normal range⁴.
Inflammatory load
Visceral adipose tissue produces pro-inflammatory cytokines (including TNF-α and IL-6) at significantly higher rates than subcutaneous fat. Chronic low-grade inflammation is one of the proposed mechanisms linking visceral fat to long-term disease risk.
The studies are not unanimous on every detail. But the broad conclusion — that visceral fat is the form most closely associated with serious long-term health outcomes — is by this point fairly settled in the literature.
The signs most patients don't realise are connected
Many of the symptoms patients describe to us informally turn out to be linked, on closer examination, to visceral adiposity.
A persistent increase in waist circumference, even when total weight has been stable for years. A change in body shape after the age of 40, particularly around the midsection. Fatigue that follows meals. Sleep that has become lighter, more fragmented, or less restorative. Blood pressure that has crept upwards. A liver enzyme reading flagged by the GP as borderline.
None of these symptoms are diagnostic on their own. Together, and in context, they often point to a metabolic picture that warrants attention.
How visceral fat is measured
In a research setting, visceral fat is measured directly using imaging — DXA scans, MRI, or CT. These methods are accurate but generally not available outside specialist services.
Clinically, two indirect measurements give a reasonable approximation:
Waist circumference
Measured at the midpoint between the lowest rib and the iliac crest, on bare skin, at the end of a normal exhale.
NICE NG246 (2025) updated waist circumference thresholds to be ethnicity-adjusted. The headline thresholds:
- For most adults, a waist measurement above 94 cm (men) or 80 cm (women) is considered an indicator of increased health risk.
- For South Asian, Chinese, Other Asian, Middle Eastern, Black African and African Caribbean ethnic groups, the corresponding thresholds are 90 cm (men) and 80 cm (women).
Waist-to-height ratio
A simpler measure that often correlates more reliably with visceral fat than waist alone⁵. The guidance to remember: keep your waist to less than half your height.
A person who is 170 cm tall, then, has a waist target of less than 85 cm. The principle holds across ethnicity, sex and age — and can be calculated by anyone, at home, with a tape measure.
What actually moves visceral fat
The evidence on lifestyle change is, by this point, considerable.
Resistance training
Multiple trials have shown that progressive resistance training reduces visceral fat — even when total body weight does not change substantially⁶. The mechanism is partly the direct effect of building muscle (which improves insulin sensitivity) and partly the change in how the body partitions stored energy.
Aerobic exercise
Higher-intensity aerobic exercise, in a sufficient weekly dose, has been shown to selectively reduce visceral fat. The intensity matters: light, infrequent activity tends not to shift visceral adiposity meaningfully⁷.
Dietary pattern
The published literature on dietary patterns is most consistent for the Mediterranean dietary pattern. The Mediterranean pattern has been associated, across multiple cohorts, with reductions in visceral fat and improvements in cardiometabolic markers⁸. Calorie counting in isolation tends not to move visceral fat as reliably as a sustained dietary pattern shift.
Sleep
Restricted or fragmented sleep is associated with higher levels of cortisol and altered insulin sensitivity — both of which favour visceral fat deposition⁹. The earliest research on this dates to the late 1990s and the pattern has held up since.
Stress
Chronic psychological stress, through elevated cortisol exposure, has been shown to encourage visceral fat accumulation independent of dietary intake. The work of Epel and colleagues (Yale, early 2000s) is often cited here.
None of these single interventions tends to work in isolation. The published evidence supports a combined approach.
When to take it seriously
A reasonable signal to seek clinical input:
- A waist measurement above the thresholds noted earlier.
- A waist-to-height ratio above 0.5.
- A family history of type 2 diabetes, cardiovascular disease, or non-alcoholic fatty liver disease.
- Symptoms that suggest possible metabolic dysregulation — fatigue after meals, sleep disruption, blood pressure that has been creeping upwards.
- Stable total weight, but a noticeable shift in where weight sits — particularly after the age of 40.
Patients in this category may benefit from a more thorough clinical assessment than the standard BMI-based screen offered in many settings.
Frequently asked questions
Can you have visceral fat at a normal weight?
Yes. The clinical literature describes this presentation as 'TOFI' — thin on the outside, fat on the inside. It is more common than is generally recognised, and it is one of the clearest reasons BMI alone is an incomplete screening tool.
Is visceral fat reversible?
The published evidence suggests that visceral fat tends to respond well to sustained lifestyle change — often more readily than subcutaneous fat. The reductions can begin within weeks of consistent change, with measurable shifts in associated cardiometabolic markers within months.
Does cortisol cause visceral fat?
Chronic exposure to elevated cortisol — for example through ongoing psychological stress or disrupted sleep — has been shown to encourage visceral fat deposition independent of calorie intake. The relationship is not direct in every individual, but it is well-documented at the population level.
How accurate is waist-to-height ratio?
Waist-to-height ratio tends to correlate more reliably with visceral fat than BMI does, particularly across ethnic groups. It is not a perfect proxy for imaging, but it is one of the most accessible measurements with reasonable clinical utility.
A note on how this is approached at VSC
Our clinical assessment process considers waist circumference and waist-to-height ratio alongside total weight. We look at family history, lived experience, and the practical patterns of the patient's life — sleep, stress, eating patterns, energy through the day. The intention is to read the whole picture, rather than rely on a single number.
If any of the above feels relevant to your situation, our clinical team is here to help you understand what your own measurements mean — and what, if anything, the evidence suggests may help.
References (citations to verify with Mohamed)
- Després JP, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–7.
- NICE. Obesity: identification, assessment and management — NICE guideline NG246. 2025.
- Neeland IJ et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA 2012; 308: 1150–9.
- Debette S et al. Visceral fat is associated with lower brain volume in healthy middle-aged adults. Annals of Neurology 2010; 68: 136–44.
- Ashwell M et al. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors. Obesity Reviews 2012; 13: 275–86.
- Slentz CA et al. Effects of aerobic vs. resistance training on visceral and liver fat stores. American Journal of Physiology 2011; 301: E1033–9.
- Verheggen RJ et al. Systematic review and meta-analysis on exercise vs. hypocaloric diet for visceral adipose tissue. Obesity Reviews 2016; 17: 664–90.
- Estruch R et al. (PREDIMED). Primary prevention of CVD with Mediterranean diet. NEJM 2018; 378: e34.
- Spiegel K, Leproult R, Van Cauter E. Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435–9.
.avif)